Study Findings on Tumor Lysis Syndrome Are Outlined in Reports from H. Lee Moffitt Cancer Center (Risks and Outcomes of Tumor Lysis Syndrome in Patients Admitted with Diffuse Large B Cell Lymphoma; A Nationwide Analysis).

Předmět:	TUMOR lysis syndrome B cell lymphoma MEDICAL personnel LYMPHOPROLIFERATIVE disorders LYMPHATIC diseases
Zdroj:	Hematology Week; 12/22/2023, p785-785, 1p
Abstrakt:	A recent study conducted by researchers at the H. Lee Moffitt Cancer Center in Tampa, Florida, examined the risks and outcomes of tumor lysis syndrome (TLS) in patients with diffuse large B cell lymphoma (DLBCL). The study analyzed data from the National Inpatient Sample Database and found that patients with DLBCL who developed TLS had a higher risk of all-cause mortality and morbidity. The researchers emphasized the importance of preventive strategies such as generous hydration and early detection of TLS to improve patient outcomes. The study provides valuable insights for healthcare professionals treating DLBCL patients. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu